Related Experiment Video
Updated: Dec 29, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Children with allergic rhinitis and a risk of epilepsy: A nationwide cohort study
Hui-Hsien Pan1, Tung-Wei Hung2, Jeng-Dau Tsai3
1Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Insights
Children with allergic rhinitis (AR) face a significantly higher risk of developing epilepsy. This study highlights a potential link between allergies and neurological conditions in children.
Area of Science:
- Pediatric Neurology
- Allergy and Immunology
- Epidemiology
Background:
- Allergic diseases are common in childhood.
- The association between allergic rhinitis and epilepsy risk is not well understood.
- Childhood-onset epilepsy poses significant health challenges.
Purpose of the Study:
- To investigate the association between allergic rhinitis (AR) and the subsequent risk of childhood-onset epilepsy.
- To determine if a history of AR increases the likelihood of developing epilepsy in children.
- To provide epidemiological data on the comorbidity of allergic rhinitis and epilepsy.
Main Methods:
- Retrospective population-based cohort study using Taiwan's National Health Insurance Research Database (2000-2012).
- Inclusion of 67,537 children diagnosed with AR and 67,537 matched controls aged 0-18 years.
- Analysis using Cox proportional hazards regression to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).
Main Results:
- Children with AR exhibited a higher incidence rate of epilepsy (6.84 vs. 3.95 per 10,000 person-years).
- The adjusted hazard ratio for epilepsy in children with AR was 1.76 (95% CI 1.51-2.04), indicating a 76% increased risk.
- Kaplan-Meier analysis showed a significantly higher likelihood of epilepsy development in children with AR (p < 0.001).
Conclusions:
- Children diagnosed with allergic rhinitis have an increased risk of developing epilepsy.
- The findings suggest a potential link between allergic rhinitis and subsequent epilepsy diagnosis in pediatric populations.
- Further research is warranted to explore the underlying mechanisms connecting AR and epilepsy.
Purpose:
Little is known about whether allergic disease is associated with a subsequent increased risk of childhood-onset epilepsy. We used a large, population-based cohort study to examine whether children with antecedent allergic rhinitis (AR) were associated with a subsequent increased risk of epilepsy.
Methods:
This retrospective population-based cohort study was conducted by using data from the 2000-2012 Taiwan's National Health Insurance Research Database. We enrolled 67,537 children aged 0-18 years diagnosed with AR and 67,537 age- and gender-matched children without the diagnosis of AR. The incidence rate (per 10,000 person-years) of epilepsy was calculated. We used Cox proportional hazards regression analysis to estimate hazard ratios (HRs) and 95 % confident interval (CI).
Results:
Of the 135,074 children included in the analyses, those with AR had a higher incidence rate of epilepsy (6.84 versus 3.95 per 10,000 person-years, p < 0.001) and an earlier age at diagnosis of epilepsy than those without AR [8.54 (4.90) versus 9.33 (5.40) years, p = 0.03)]. The Kaplan-Meier survival analysis demonstrated that the children with AR had a higher likelihood of developing epilepsy than those without AR (p < 0.001). After adjusting for confounding factors in multivariate model, children with AR had a 76 % increased risk of epilepsy (HR 1.76, 95 % CI 1.51-2.04) than those without AR. Boys had a 21 % increased risk of epilepsy (HR 1.21, 95 % CI 1.05-1.40) than girls.
Conclusions:
These results suggest that children with AR were associated with an increased subsequent risk of epilepsy.
Related Concept Videos
Allergic Reactions
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Drug Reactions
Asthma-III: Symptoms and Complications
Classification of Asthma

